ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD.

Autres langues Zylox-Tonbridge Medical Technology Co., Ltd.

Actions

2190

CNE100004JD2

Marché Fermé - Hong Kong S.E. Autres places de cotation 10:09:09 25/04/2024			Varia. 5j.	Varia. 1 janv.
10,24 ^HKD	-2,48 %		+8,02 %	-17,68 %

22/03	Zylox-Tonbridge réduit sa perte de 31% pour l'exercice 2023	MT
21/03	Zylox-Tonbridge Medical Technology Co. annonce ses résultats pour l'exercice clos le 31 décembre 2023	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Zylox-Tonbridge Shrinks Loss by 31% in Fiscal 2023	22/03
Zylox-Tonbridge Medical Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	21/03
Avinger in Equity Funding Partnership With Chinese Medical Device Firm, Unveils Debt-Terms Extension; Shares Rise Premarket	07/03
Zylox-Tonbridge Enters Licensing, Investment Contracts with American Innovative Medical Device Maker	07/03
Avinger, Inc. Announces New Strategic Partnership with Zylox-Tonbridge Medical Technology Co., Ltd	07/03
Avinger, Inc. announced that it expects to receive $15 million in funding from Zylox-Tonbridge Medical Technology Co., Ltd.	04/03
Zylox-Tonbridge Receives Marketing Approvals for Multiple Products in the UAE	21/02
China Grants Marketing Approval to Zylox-Tonbridge's Peripheral Venous Stent System; Shares Fall 7%	22/01
Zylox-Tonbridge Medical Technology Co., Ltd Receives Marketing Approval from National Medical Products Administration Grants Marketing for Zylox® Penguin Peripheral Venous Stent System	22/01
Zylox-Tonbridge Medical Technology Co., Ltd. Announces National Medical Products Administration Grants Marketing Approval for Zylox Phoenix Peripheral Detachable Fibrous Coil Embolization System	29/12
Zylox Tonbridge Secures Chinese Marketing Approval for Arterial Embolization Device	29/12
Zylox-Tonbridge Completes Patient Enrolment for Post-Marketing Clinical Trial of Stent System in EU	21/12
Zylox-Tonbridge Medical Technology Co., Ltd. Completes Enrollment of All 100 Patients in the Multi-Center Clinical Trial in Germany	20/12
Zylox-Tonbridge Medical Technology Co., Ltd. Receives Official Marketing Approval	11/12
China Grants Marketing Approval to Zylox-Tonbridge's Balloon Catheter	11/12
China Gives Marketing Approval for Zylox-Tonbridge's Blood Vessel Distal Support Catheter	06/12
Zylox-Tonbridge Medical Technology Co., Ltd. Announces Change of Address of Registered Office	07/11
Zylox-Tonbridge Medical Technology Co., Ltd. commences an Equity Buyback Plan for 32,461,974 shares, representing 10% of its issued share capital, under the authorization approved on June 6, 2023.	07/11
Zylox-Tonbridge Trustee Buys About 1.1 Million Shares Under Share Award, Trust Scheme; Shares Jump 5%	06/11
Zylox-Tonbridge Medical Buys Back 1.1 Million Shares	13/10/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Zylox-Tonbridge Medical Technology Co., Ltd.

Actions

2190

CNE100004JD2

Autres langues

Filtres